High-dose steroids for the treatment of severe COVID-19: a new therapeutic tool?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Emergency Medicine,Internal Medicine
Link
https://link.springer.com/content/pdf/10.1007/s11739-021-02722-y.pdf
Reference8 articles.
1. Piccica M, Lagi F, Trotta M, Spinicci M, Zammarchi L, Bartoloni A, for the COCORA working group. High-dose steroids for the treatment of severe COVID-19. https://doi.org/10.1007/s11739-021-02707-x
2. RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL et al (2021) Dexamethasone in hospitalized patients with COVID-19. N Engl J Med 384(8):693–704
3. Lora-Tamayo J, Maestro G, Lalueza A, Rubio-Rivas M, Villarreal Paul G, Arnalich Fernández F et al (2021) Early Lopinavir/ritonavir does not reduce mortality in COVID-19 patients: Results of a large multicenter study. J Infect. https://doi.org/10.1016/j.jinf.2021.02.011
4. RECOVERY Collaborative Group, Horby P, Mafham M, Linsell L, Bell JL, Staplin N et al (2020) Effect of hydroxychloroquine in hospitalized patients with COVID-19. N Engl J Med 383(21):2030–2040
5. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC et al (2020) Remdesivir for the treatment of COVID-19—final report. N Engl J Med 383(19):1813–1826
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Peculiarities of the cytokine profile in patients hospitalized due to a combination of coronavirus disease and arterial hypertension;Experimental and Clinical Physiology and Biochemistry;2023-06-29
2. Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review;Frontiers in Pharmacology;2022-03-04
3. Cytokine profiles in the detection of severe lung involvement in hospitalized patients with COVID-19: The IL-8/IL-32 axis;Cytokine;2022-03
4. NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19;Cells;2021-11-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3